SUBCUTANEOUS ADMINISTRATION OF LONG-ACTING FACTOR IX IN HUMANS
- 专利权人:
- CSL BEHRING LENGNAU AG
- 发明人:
- VOIGT, CHRISTINE,PULI, SHILPA,ROBERTS, JOHN,NOLTE, MARC
- 申请号:
- CA3029887
- 公开号:
- CA3029887A1
- 申请日:
- 2017.07.07
- 申请国别(地区):
- CA
- 年份:
- 2018
- 代理人:
- 摘要:
- The present invention relates to clinically relevant dosing regimens of prophylactic subcutaneously administered long-acting factor IX (i.e., human FIX fused to human albumin) in human patients.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- SUBCUTANEOUS ADMINISTRATION OF LONG-ACTING FACTOR IX IN HUMANS
- Subcutaneous administration of long-acting factor IX in humans
- 21-day dosing regimen for fusion proteins comprising factor IX and human albumin for prophylactic treatment of hemophilia and methods thereof
- 21-DAY DOSING REGIMEN FOR FUSION PROTEINS COMPRISING FACTOR IX AND HUMAN ALBUMIN FOR PROPHYLACTIC TREATMENT OF HEMOPHILIA AND METHODS THEREOF
- משטר נטילת תרופה של 21 יום לחלבונים מאוחים המכיל פקטור ix ואלבומין אנושי עבור טיפולים מונעי המופיליה ושיטות שלהם